Pentoxifylline
Pentoxifylline is a pharmaceutical drug with 115 clinical trials. Currently 13 active trials ongoing. Historical success rate of 85.5%.
Success Metrics
Based on 59 completed trials
Phase Distribution
Phase Distribution
19
Early Stage
40
Mid Stage
30
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.9%
59 of 72 finished
18.1%
13 ended early
13
trials recruiting
115
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation
Efficacy, Satisfaction, and Safety of the Mesolipo® Protocol for the Treatment of Localized Adiposity
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
Evaluation of Efficacy, Safety and Molecular Mechanism of Pentoxifylline Supplementation in Patients With Hepatic and Obstructive Jaundice
Cocaine and Pentoxifylline (BED IN 47)
Clinical Trials (115)
Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation
Efficacy, Satisfaction, and Safety of the Mesolipo® Protocol for the Treatment of Localized Adiposity
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
Evaluation of Efficacy, Safety and Molecular Mechanism of Pentoxifylline Supplementation in Patients With Hepatic and Obstructive Jaundice
Cocaine and Pentoxifylline (BED IN 47)
Pentoxifylline for Prevention of Contrast Induced Nephropathy in Chronic Kidney Diseased Patients in Intensive Care Unit
Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)
Pentoxifylline in Patients With Ulcerative Colitis
Pentoxifylline in Diabetic Kidney Disease
RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine
Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)
Pentoxifylline on Inflammatory Markers in Non-Diabetic Chronic Kidney Disease Patients
Pentoxifylline as Anti-Inflammatory in Patients With Rheumatoid Arthritis
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Pentoxifylline Versus Cilostazol
Nephroprotection Following Perinatal Asphyxia: Randomized Controlled Trial
The Efficacy of Using Pentoxifylline in Patients Undergoing Breast Cancer Surgery
Metformin Repurposing in Oral Submucous Fibrosis: Unveiling In Vitro Signaling Pathways, Progressing to Clinical Trial
Bioequivalence Study of Pentoxifylline 400 Mg in Healthy Subjects Under Fasting and Fed Conditions
Trental for the Treatment of Vertigo/Dizziness/Imbalance
Pentoxifylline Role Against Chemotherapy-induced Neuropathy
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 115